1. Home
  2. MATW vs PHAT Comparison

MATW vs PHAT Comparison

Compare MATW & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATW
  • PHAT
  • Stock Information
  • Founded
  • MATW 1850
  • PHAT 2018
  • Country
  • MATW United States
  • PHAT United States
  • Employees
  • MATW N/A
  • PHAT N/A
  • Industry
  • MATW Metal Fabrications
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATW Telecommunications
  • PHAT Health Care
  • Exchange
  • MATW Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • MATW 654.6M
  • PHAT 727.5M
  • IPO Year
  • MATW 1994
  • PHAT 2019
  • Fundamental
  • Price
  • MATW $25.30
  • PHAT $9.45
  • Analyst Decision
  • MATW Strong Buy
  • PHAT Strong Buy
  • Analyst Count
  • MATW 1
  • PHAT 5
  • Target Price
  • MATW $40.00
  • PHAT $16.40
  • AVG Volume (30 Days)
  • MATW 206.0K
  • PHAT 1.9M
  • Earning Date
  • MATW 08-05-2025
  • PHAT 08-07-2025
  • Dividend Yield
  • MATW 3.87%
  • PHAT N/A
  • EPS Growth
  • MATW N/A
  • PHAT N/A
  • EPS
  • MATW N/A
  • PHAT N/A
  • Revenue
  • MATW $1,703,999,000.00
  • PHAT $81,859,000.00
  • Revenue This Year
  • MATW N/A
  • PHAT $195.45
  • Revenue Next Year
  • MATW N/A
  • PHAT $106.76
  • P/E Ratio
  • MATW N/A
  • PHAT N/A
  • Revenue Growth
  • MATW N/A
  • PHAT 3055.70
  • 52 Week Low
  • MATW $18.50
  • PHAT $2.21
  • 52 Week High
  • MATW $32.24
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • MATW 62.95
  • PHAT 60.80
  • Support Level
  • MATW $24.17
  • PHAT $8.19
  • Resistance Level
  • MATW $25.90
  • PHAT $9.76
  • Average True Range (ATR)
  • MATW 0.98
  • PHAT 0.66
  • MACD
  • MATW 0.17
  • PHAT -0.21
  • Stochastic Oscillator
  • MATW 88.37
  • PHAT 54.58

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: